Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Neoplasms × Lidocaine × Clear all

Sponsor

Conditions

Prostatic Neoplasms 2 Neuralgia 2 Neoplasms 2 Lung Neoplasms 2 Sexual Dysfunction, Physiological 1 Pneumonia 1 Pain 1 Neuropathy, Painful 1 Neurofibromatoses 1 Neoplasms, Cystic, Mucinous, and Serous 1 Mastodynia 1 Lymphoma, Follicular 1 Leukemia-Lymphoma 1 Leiomyoma 1 Kidney Neoplasms 1 Ileus 1 Hydrocephalus 1 Hordeolum 1 Headache 1 Eyelid Neoplasms 1 Epilepsy 1 Colorectal Neoplasms 1 Cold Hypersensitivity 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Breast Neoplasms 1 Abdominal Neoplasms 1

Interventions

vandetanib 7 lenvatinib 5 cabozantinib 4 Sunitinib 4 Sorafenib 4 AZD 6244 3 selpercatinib 2 durvalumab 2 alectinib 2 Triiodothyronine 2 Thyroxine 2 Paclitaxel 2 Iodine-131 2 Everolimus 2 Bortezomib 2 Axitinib 2 tremelimumab 1 tipifarnib 1 temsirolimus 1 tanespimycin 1 sapanisertib 1 regorafenib 1 pralsetinib 1 ponatinib 1 perflutren 1 pazopanib 1 pasireotide 1 methyl N-acetylsibirosaminide 1 gallium 68 PSMA-11 1 fosbretabulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡